NCT07302893

Brief Summary

Sleep disturbances are highly prevalent during the postpartum period, with an estimated 40-60% of new parents experiencing inadequate sleep. Although a certain degree of acute sleep disruption is expected after childbirth, excessive or prolonged disturbances can pose significant risks, including poorer cardiometabolic and mental health, impaired cognitive performance, and challenges in bonding with the infant. In addition, untreated insomnia in the perinatal period can lead to more chronic forms of insomnia in some individuals that extends beyond the perinatal period. Cognitive Behavioral Therapy for Insomnia (CBT-I) is widely recognized as the gold standard treatment for chronic insomnia, demonstrating robust efficacy in diverse populations. However, its applicability in the postpartum period remains underexplored. New parents face a distinct set of sleep challenges, most notably, a significant loss of control over their sleep schedules due to infant care demands. This unpredictability complicates the implementation of core CBT-I techniques such as sleep restriction and stimulus control. Additionally, postpartum parents often experience heightened fatigue, limited time, and cognitive overload, potentially reducing their ability to engage with and retain behavioral or educational interventions. This study addresses a significant gap in sleep health research by evaluating whether a modified digital CBT-I intervention, enhanced with brief meditation content, can improve self-reported sleep outcomes in new parents. By including both immediate (post-intervention) and longer-term (3-month follow-up) outcomes, the study aligns with broader public health goals of reducing mental health morbidity and improving functioning in the perinatal population. The Headspace Health Sleep Program is an 18 day program based on CBT-I, which includes the following intervention components: 1) a sleep diary to monitor sleep and associated factors; 2) cognitive interventions to address maladaptive thoughts related to sleep; 3) behavioral interventions to address maladaptive behaviors related to sleep (e.g., sleep hygiene, stimulus control, and sleep restriction); 4) de-arousal techniques (e.g., mindfulness, breathing, and muscle relaxation exercises).

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
4mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Jan 2026Sep 2026

First Submitted

Initial submission to the registry

December 11, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2026

Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

6 months

First QC Date

December 11, 2025

Last Update Submit

December 11, 2025

Conditions

Keywords

postpartumCBT-I

Outcome Measures

Primary Outcomes (2)

  • Insomnia Severity Index (ISI) score

    The ISI is a measure of sleep disturbance severity. ISI is a 7-item, self-report measure for the evaluation of insomnia. Items in the ISI concern difficulties falling asleep, problems staying asleep, daytime symptoms connected to the sleeping problem, and worrying about sleeping too little. Each item is rated from 0 to 4, giving the rating scale a maximum summed score of 28 points. According to the guidelines for interpretation, 0-7 should be interpreted as no clinically significant insomnia, 8-14 as subthreshold insomnia, 15-21 as clinical insomnia of moderate severity, and 22-28 as severe clinical insomnia.

    Change from baseline to immediately post-intervention and 3 months follow-up

  • Sleep Diary

    Participants will be asked to complete a daily sleep diary for the duration of the 1-week baseline assessment period and the 1-week post-intervention assessment and the 1-week follow-up period. The sleep diary will be used to measure sleep efficiency (SE) and total wake time (TWT). Sleep efficiency will be calculated by dividing the amount of time sleeping in bed by the amount of time spent in bed. Total sleep time will be calculated as the total amount of nightly sleep. In addition, the sleep diary will measure sleep onset latency (SOL), wake after sleep onset (WASO). The sleep diary data will be averaged across one week with a minimum of 4 nights required for inclusion.

    Change from baseline to immediately post-intervention and 3 month follow-up

Secondary Outcomes (3)

  • The Pittsburgh Sleep Quality Index (PSQI)

    Change from baseline to immediately post-intervention and 3 months follow-up

  • Perceived Stress Scale (PSS-10)

    Change from baseline to immediately post-intervention and 3 months follow-up

  • General Anxiety Disorder-7 (GAD-7)

    Change from baseline to immediately post-intervention and 3-months follow-up

Study Arms (2)

Digital CBT-I recipients

EXPERIMENTAL

instructed to follow the 18-session Headspace sleep program daily

Behavioral: Digital CBT-I

No intervention

NO INTERVENTION

asked to maintain their regular routines

Interventions

Digital CBT-IBEHAVIORAL

Headspace 18-session sleep program

Digital CBT-I recipients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First time parents with infants between 4-12 months of age
  • Caregiver is over 18 years old
  • Caregiver meets clinical threshold for insomnia (11 or greater on the ISI)
  • Own a smartphone that can support downloaded apps
  • Fluency in English

You may not qualify if:

  • A diagnosis of any of the following conditions: self-reported schizophrenia, psychosis, depression, self-harm bipolar disorder, seizure disorder, substance use disorder, recent trauma to the head or brain damage, severe cognitive impairment, serious physical health concerns necessitating surgery or with a prognosis of less than 6 months, or pregnancy. Two or more hospitalizations within the past 6 months for psychiatric reasons.
  • Prior enrollment in another CBT-I program
  • Regular mindfulness meditation practice
  • Diagnosed sleep disordered breathing
  • Parents of infants with health complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanit office

New York, New York, 10013, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Central Study Contacts

Maristella Lucchini, Senior Clinical Researcher at Nanit, PhD

CONTACT

Natalie Barnett, VP of Clinical Research at Nanit, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2025

First Posted

December 24, 2025

Study Start

January 15, 2026

Primary Completion (Estimated)

July 15, 2026

Study Completion (Estimated)

September 15, 2026

Last Updated

December 24, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

Aggregated data collected in this project will be de-identified and made available on a shared secured data repository. Results from this project will be shared and disseminated, including manuscripts will be written and submitted for publication in peer-reviewed journals/conferences. All necessary ethical approvals will be obtained.

Time Frame
Data will be made available upon request after dissemination of results.

Locations